This session focuses on patients with kidney disease who also have various blood dyscrasias. Causes and symptoms of blood dyscrasias as well as medical and nursing interventions for treatment plans are highlighted. Pharmacologic therapies also are reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare. Speaker Disclosures: Indumathy Varadarajan, MBBS - Consultant and Advisory Board Member for Kite Pharmaceuticals.
There are no other speaker disclosures to declare.
Commercial Support: No commercial support declared. Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity, the learner will be able to verbalize elements of care planning for CKD patients with blood dyscrasias.